This company listing is no longer active
Amur Minerals (A7L) Stock Overview
Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
A7L Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
An Undervalued 3.3Moz Gold Project in Canada
Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read more
Amur Minerals Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.004 |
| 52 Week High | UK£0.029 |
| 52 Week Low | UK£0.002 |
| Beta | 0.028 |
| 1 Month Change | 0% |
| 3 Month Change | -81.40% |
| 1 Year Change | -38.46% |
| 3 Year Change | -73.33% |
| 5 Year Change | -90.00% |
| Change since IPO | -98.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| A7L | DE Metals and Mining | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | 0.2% |
| 1Y | -38.5% | 15.2% | -1.9% |
Return vs Industry: A7L underperformed the German Metals and Mining industry which returned 1.7% over the past year.
Return vs Market: A7L underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| A7L volatility | |
|---|---|
| A7L Average Weekly Movement | n/a |
| Metals and Mining Industry Average Movement | 10.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in DE Market | 14.3% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: A7L's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A7L's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 16 | Bob Young | www.crismtherapeutics.com |
Amur Minerals Corporation, together with its subsidiaries, engages in locating, evaluating, acquiring, exploring, and developing mineral properties and projects in the Far East of Russia. The company was incorporated in 2004 and is based in Road Town, British Virgin Islands.
Amur Minerals Corporation Fundamentals Summary
| A7L fundamental statistics | |
|---|---|
| Market cap | €1.95m |
| Earnings (TTM) | -€2.41m |
| Revenue (TTM) | n/a |
Is A7L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A7L income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.61m |
| Earnings | -US$2.60m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did A7L perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/08/29 15:22 |
| End of Day Share Price | 2023/06/01 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CRISM Therapeutics Corporation is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lord Ashbourne | Edison Investment Research |
| Desmond Kilalea | RBC Capital Markets |